Dupuytren's Contracture
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Pulse BiosciencesCA - Hayward
1 programReal-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's ContractureN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PfizerXiapex
Pulse BiosciencesReal-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
Clinical Trials (2)
Total enrollment: 254 patients across 2 trials
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
Start: Dec 2010Est. completion: Oct 2012254 patients
Phase 3Completed
NCT05877066Pulse BiosciencesReal-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
Start: Jun 2023Est. completion: Feb 2024
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space